Introduction
Karen Lynch and Phebe Novakovic are two highly accomplished American business leaders whose careers have reached the highest levels of corporate leadership. Although they work in different industries, both have built reputations through strategic thinking, operational experience, and leadership of large organizations.
Karen Lynch is best known for her leadership in health care and insurance. She served as President and CEO of CVS Health from 2021 through 2024 after previously leading Aetna. In 2025, she joined the board of Thermo Fisher Scientific and remains a director there in 2026.
Phebe Novakovic is best known for her leadership in aerospace and defense. She has served as Chairman and CEO of General Dynamics since 2013 and is also a director of JPMorgan Chase.
Their stories are different, but both demonstrate how senior executives can build influence across complex and highly regulated industries.
Quick Biography Table
| Category | Karen Lynch | Phebe Novakovic |
|---|---|---|
| Full Name | Karen S. Lynch | Phebe N. Novakovic |
| Main Industry | Health care and insurance | Aerospace and defense |
| Former Major Executive Role | President and CEO, CVS Health | Chairman and CEO, General Dynamics |
| CVS Health Leadership | 2021–2024 | Not applicable |
| General Dynamics Leadership | Not applicable | Chairman and CEO since 2013 |
| Current Board Role | Thermo Fisher Scientific | JPMorgan Chase |
| Earlier Career | Ernst & Young, Cigna, Magellan Health, Aetna | U.S. government, General Dynamics |
| Education | Accounting and business background | Smith College; Wharton MBA |
| Known For | Health-care transformation | Aerospace, defense and corporate leadership |
Karen Lynch Biography
Karen S. Lynch built a career spanning accounting, health insurance, health services, and corporate leadership. She began her professional career as a certified public accountant at Ernst & Young. She later held senior positions at Cigna and Magellan Health before joining Aetna.
Her career at Aetna became an important step toward the top of the health-care industry. She eventually became President of Aetna and later served as Executive Vice President of CVS Health.
In November 2020, CVS Health announced that Lynch would become its next President and CEO. She officially took over the position on February 1, 2021.
Her tenure came during a major period of change in American health care. CVS Health was expanding beyond traditional pharmacy operations and integrating businesses across pharmacy, insurance, and health services.
Karen Lynch’s Leadership at CVS Health
Lynch became one of the most prominent female executives in the health-care industry during her time at CVS Health. Her responsibilities included overseeing a large organization operating across several parts of the health-care system.
During her leadership, CVS Health continued developing its integrated health-care strategy. The company expanded its care-delivery capabilities and completed major acquisitions, including Signify Health and Oak Street Health in 2023.
Lynch’s time as CEO ended in 2024. David Joyner succeeded her as President and CEO of CVS Health. Current CVS Health leadership information identifies Joyner as Chairman and CEO.
This distinction is important in a 2026 biography because older online articles may still describe Lynch as the current CVS Health CEO.
Karen Lynch in 2026
Karen Lynch remains active in corporate leadership after leaving CVS Health. Thermo Fisher Scientific elected her to its board of directors in February 2025. The company’s current board information lists her as a director.
Thermo Fisher also notes that Lynch previously served as President and CEO of CVS Health from 2021 to 2024 and as President of Aetna. It identifies her current additional public-company directorship as ADP.
Her move into board leadership reflects another stage of her career. Instead of running a large health-care company as its chief executive, she now contributes experience in strategy, finance, governance, health care, and mergers and acquisitions.
Phebe Novakovic Biography
Phebe N. Novakovic is an American business executive best known for her long association with General Dynamics, one of the world’s major aerospace and defense companies.
Novakovic joined General Dynamics in 2001 and held several executive positions before becoming President and Chief Operating Officer in 2012. She became Chairman and CEO in 2013.
Her earlier career also included significant government experience. Her background included work with the Office of Management and Budget and service as a Special Assistant to the Secretary and Deputy Secretary of Defense. This combination gave her experience in government, defense, strategy, and complex organizational management.
Phebe Novakovic’s Education and Corporate Career
Novakovic graduated from Smith College and later earned an MBA from the Wharton School of the University of Pennsylvania.
Her General Dynamics career developed through increasingly senior positions. She served as Vice President from 2002 to 2005, Senior Vice President of Planning and Development from 2005 to 2012, and Executive Vice President of Marine Systems from 2010 to 2012. She then became President and COO before taking the top leadership position in 2013.
Her career demonstrates a gradual progression through strategy, operations, and executive management rather than a sudden rise to the CEO position.
Phebe Novakovic in 2026
Phebe Novakovic continues to serve as Chairman and CEO of General Dynamics in 2026. She is also a member of the JPMorgan Chase board, where she has served since 2020. JPMorgan Chase’s current leadership information lists her as a director.
The 2026 JPMorgan Chase proxy supplement lists Novakovic among the company’s board nominees and records six years of board tenure.
She also serves on JPMorgan Chase’s Audit Committee and Public Responsibility Committee.
Her continued role at General Dynamics makes her one of the longest-serving women leading a major U.S. aerospace and defense company.
Karen Lynch and Phebe Novakovic: Is There a Direct Connection?
The keyword “Karen Lynch and Phebe Novakovic” can suggest that the two women have a direct personal or professional relationship. However, available corporate biographies do not establish that they are relatives, business partners, or former colleagues.
Their connection is better understood through their careers as influential women in corporate leadership.
Lynch built her reputation primarily in health care, insurance, and health services. Novakovic developed her career around aerospace, defense, government, strategy, and corporate management.
There is, however, an important similarity in their current careers. Both have experience serving on the boards of major public companies. Lynch is a Thermo Fisher Scientific director, while Novakovic serves on the JPMorgan Chase board.
Karen Lynch vs. Phebe Novakovic
The biggest difference between Karen Lynch and Phebe Novakovic is their industry background.
Lynch spent most of her career in health care and insurance. Her leadership experience includes Aetna, CVS Health, and other health-care organizations.
Novakovic’s career has been focused on aerospace, defense, government, and corporate strategy. Her position at General Dynamics places her at the center of a highly complex global industry.
Despite these differences, both careers share several themes. Both executives managed large organizations, worked in highly regulated environments, and developed extensive experience in corporate governance.
Why Karen Lynch and Phebe Novakovic Matter in 2026
In 2026, both executives remain relevant because their careers show two different models of modern corporate leadership.
Lynch represents leadership in the rapidly changing health-care sector. Her current board work allows her to apply decades of health-care, financial, and executive experience beyond her former CEO role.
Novakovic represents long-term leadership in aerospace and defense. Her continued position at General Dynamics, combined with her JPMorgan Chase board service, gives her influence across both industry and corporate governance.
Their careers also show that reaching the CEO level does not necessarily mark the end of professional growth. Both have continued building their influence through board and governance responsibilities.
Frequently Asked Questions
Are Karen Lynch and Phebe Novakovic related?
There is no reliable public evidence establishing that Karen Lynch and Phebe Novakovic are related.
Is Karen Lynch still CEO of CVS Health in 2026?
No. Lynch served as CVS Health President and CEO from 2021 through 2024. David Joyner is the company’s current Chairman and CEO.
What does Karen Lynch do in 2026?
Lynch serves on the board of Thermo Fisher Scientific and also has a current directorship with ADP, according to Thermo Fisher’s board biography.
Is Phebe Novakovic still CEO of General Dynamics?
Yes. Phebe Novakovic has served as Chairman and CEO of General Dynamics since 2013.
What is Phebe Novakovic known for?
She is known for her leadership of General Dynamics and for her earlier government and defense-related experience. She also serves on the JPMorgan Chase board.
Conclusion
Karen Lynch and Phebe Novakovic are two powerful examples of women who reached senior leadership positions in very different industries. Lynch established her reputation through health care, insurance, finance, and business transformation before moving into corporate board leadership. Novakovic built a long career in government, defense, strategy, and aerospace and continues to lead General Dynamics.
The two are not publicly documented as having a major direct personal relationship. Their strongest connection is their shared position as highly accomplished corporate leaders with experience in major public-company governance.
As of 2026, Karen Lynch’s career is centered increasingly on board leadership, while Phebe Novakovic continues in an active CEO role at General Dynamics. Their careers offer useful examples of strategic leadership, professional progression, and long-term influence in American business.
Read More: Peter Thiel and Kevin Hart: Biography, Careers, Success, and Their Connection